Discovery Life Sciences to Acquire Gentest Business from Corning Incorporated

BIOSPECIMEN LEADER TO COMBINE GENTEST WITH RECENT IVAL ACQUISITION TO CREATE LEADING IN VITRO DRUG METABOLISM SERVICES OFFERING HUNTSVILLE, Ala., April 5, 2022 /PRNewswire/ — Discovery Life Sciences™ (Discovery), the biospecimen and biomarker specialists™, announced today that it has…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.